Ryukou K, Date Y, Iwanari O, Miyako J, Yoshino N, Aoki S, Kitao M, Yoshikawa K, Fujita Y, Yasui K
Dept. of Obstetrics and Gynecology, Shimane Medical University.
Gan To Kagaku Ryoho. 1989 Aug;16(8 Pt 2):2797-800.
Selective intra arterial hypertensive infusion of CDDP (100 mg) and PEP (40 mg) with angiotensin II was performed in a 64 year-old housewife with inoperable uterine cervical cancer stage IVa and transitional cell cancer of bladder (grade 1-2). PEP at 5 mg/day was also administered for 20 days (total 100 mg) using an implanted Drug Delivery System through the left internal iliac artery combined with irradiation therapy. There were hardly any side effects due to this treatment except for a slight upper digestive tract disturbance and bone marrow suppression, and the cancerous lesion gradually regressed following this treatment. This case suggested the efficacy of intra-arterial infusion using an implanted Drug Delivery System for advanced uterine cervical cancer. There has been no sign of recurrence six months after this treatment.